|Last Price$38.55||Day Change (%)-0.77%|
|Open Price$38.80||Day Change ($)-0.30|
|Day Range38.21–38.83||52-Week Range36.00–51.74|
As of Tue 5/3/2016 6:45:00 PM | USD
Robbins Arroyo LLP: Acquisition of St. Jude Medical, Inc. (STJ) by Abbott Laboratories ( ABT ) May Not Be in Shareholders' Best Interests
New Avon Appoints Abbott Labs Executive as New CEO
A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.
Simple formulas for foreign exposure lose luster.
Alere Says It Rejected Abbott Offer to Terminate Merger Deal
Alere Says It Rejected Abbott Offer to End Their Merger Deal
Robbins Arroyo LLP: Alere, Inc. (ALR) Misled Shareholders According to a Recently Filed Class Action
Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in Alere Inc. (NYSE: ALR) Securities Case
Intellia Therapeutics Appoints Perry Karsen as Chairman of Its Board of Directors
argenx and AbbVie to Collaborate on ARGX-115 Against Novel Immuno-Oncology Target